Cargando…

Renal function during rofecoxib therapy in patients with metastatic cancer: retrospective analysis of a prospective phase II trial

BACKGROUND: Angiostatic/antiinflammatory therapy with COX-II inhibitors and pioglitazone seems to be a well tolerated and promising regimen in patients with metastatic cancer. COX-II inhibitors may have less gastrointestinal side effects than conventional non-steroidal antiinflammatory drugs, but th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reinhold, Stephan W, Reichle, Albrecht, Leiminger, Sonja, Bergler, Tobias, Hoffmann, Ute, Krüger, Bernd, Banas, Bernhard, Krämer, Bernhard K
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038926/ https://www.ncbi.nlm.nih.gov/pubmed/21208422 http://dx.doi.org/10.1186/1756-0500-4-2

Ejemplares similares

Synergistic effect of gefitinib and rofecoxib in mesothelioma cells
por: Stoppoloni, Daniela, et al.
Publicado: (2010)

Selective inhibition of prostacyclin synthase activity by rofecoxib
por: Griffoni, Cristiana, et al.
Publicado: (2007)

B Cell Activating Factor (BAFF) Is Required for the Development of Intra-Renal Tertiary Lymphoid Organs in Experimental Kidney Transplantation in Rats
por: Steines, Louisa, et al.
Publicado: (2020)

Rofecoxib for dysmenorrhoea: meta-analysis using individual patient data
por: Edwards, Jayne E, et al.
Publicado: (2004)

C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation
por: Reichle, Albrecht, et al.
Publicado: (2007)

Individual patient meta-analysis of single-dose rofecoxib in postoperative pain
por: Edwards, Jayne E, et al.
Publicado: (2004)

A comparison of the effects of ibuprofen and rofecoxib on rabbit fibula osteotomy healing
por: O'Connor, J Patrick, et al.
Publicado: (2009)

Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion
por: Brenner, Gábor B., et al.
Publicado: (2020)

Identification of New Rofecoxib-Based Cyclooxygenase-2 Inhibitors: A Bioinformatics Approach
por: Leão, Rozires P., et al.
Publicado: (2020)

Development and validation of an HPLC method for determination of rofecoxib in bovine serum albumin microspheres
por: DEMİRTÜRK, Esra, et al.
Publicado: (2020)

Risk/benefit trade-offs in rheumatology: rofecoxib revisited in the era of JAK inhibitors
por: Hazlewood, Glen S
Publicado: (2023)

Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy
por: Kühne, Louisa, et al.
Publicado: (2017)

Single-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic review
por: Barden, Jodie, et al.
Publicado: (2002)

Rofecoxib Attenuates the Pathogenesis of Amyotrophic Lateral Sclerosis by Alleviating Cyclooxygenase-2-Mediated Mechanisms
por: Zou, Yan-Hui, et al.
Publicado: (2020)

Carboranyl Derivatives of Rofecoxib with Cytostatic Activity against Human Melanoma and Colon Cancer Cells
por: Buzharevski, Antonio, et al.
Publicado: (2020)

The Tell-Tale Heart: Population-Based Surveillance Reveals an Association of Rofecoxib and Celecoxib with Myocardial Infarction
por: Brownstein, John S., et al.
Publicado: (2007)

A Study on Improvement of Solubility of Rofecoxib and its effect on Permeation of Drug from Topical Formulations
por: Kulkarni, Madhur, et al.
Publicado: (2008)

Disruption of Tfh:B Cell Interactions Prevents Antibody-Mediated Rejection in a Kidney Transplant Model in Rats: Impact of Calcineurin Inhibitor Dose
por: Steines, Louisa, et al.
Publicado: (2021)

Short-Term Efficacy of Rofecoxib and Diclofenac in Acute Shoulder Pain: A Placebo-Controlled Randomized Trial
por: Dougados, Maxime, et al.
Publicado: (2007)

Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine
por: Krymchantowski, Abouch Valenty, et al.
Publicado: (2004)

Comparación del rofecoxib versus paracetamol en el tratamiento del dolor en la gonartrosis
por: Santiago Ortiz, Ramón
Publicado: (2004)

Lack of Small Intestinal Dysbiosis Following Long-Term Selective Inhibition of Cyclooxygenase-2 by Rofecoxib in the Rat
por: Lázár, Bernadette, et al.
Publicado: (2019)

Infiltration of Macrophages Correlates with Severity of Allograft Rejection and Outcome in Human Kidney Transplantation
por: Bergler, Tobias, et al.
Publicado: (2016)

Dickkopf 3—A New Indicator for the Deterioration of Allograft Function After Kidney Transplantation
por: Schuster, Antonia, et al.
Publicado: (2022)

Factors influencing the time-intensity curve analysis of contrast-enhanced ultrasound in kidney transplanted patients: Toward a standardized contrast-enhanced ultrasound examination
por: Friedl, Sarah, et al.
Publicado: (2022)

Correction: Short-Term Efficacy of Rofecoxib and Diclofenac in Acute Shoulder Pain: A Placebo-Controlled Randomized Trial
Publicado: (2007)

Rofecoxib prevents ctdsDNA against damage induced by copper sulfate and ultraviolet B radiation in vitro study
por: Al-Nimer, Marwan S. M., et al.
Publicado: (2010)

Renin, endothelial no synthase and endothelin gene expression in the 2Kidney-1clip goldblatt model of long-term renovascular hypertension
por: Reinhold, SW, et al.
Publicado: (2009)

Incidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam, and rofecoxib during the first year after marketing in the United Kingdom
por: Raber, Anna, et al.
Publicado: (2007)

COX-2 Inhibition by Use of Rofecoxib or High Dose Aspirin Enhances ADP-Induced Platelet Aggregation in Fresh Blood
por: Borgdorff, Piet, et al.
Publicado: (2010)

Safe Long-Term Outcome After Kidney Donation in Older Donors: A Single-Center Experience
por: Schuster, Antonia, et al.
Publicado: (2020)

Structural Examination of 6-Methylsulphonylphenanthro-[9,10-C]-furan-1(3H)-one—A Rofecoxib Degradation Product
por: Dean, Pamela M.
Publicado: (2010)

Capecitabine in hormone-resistant metastatic prostatic carcinoma – a phase II trial
por: Morant, R, et al.
Publicado: (2004)

Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma
por: Waters, J S, et al.
Publicado: (2004)

Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma
por: Deplanque, G, et al.
Publicado: (2004)

A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients
por: Stricker, Kirstin, et al.
Publicado: (2008)

Can Electronic Health Records Databases Complement Spontaneous Reporting System Databases? A Historical-Reconstruction of the Association of Rofecoxib and Acute Myocardial Infarction
por: Patadia, Vaishali K., et al.
Publicado: (2018)

Facile Transformation from Rofecoxib to a New Near-Infrared Lipid Droplet Fluorescent Probe and Its Investigations on AIE Property, Solvatochromism and Mechanochromism
por: Wei, Yongbo, et al.
Publicado: (2023)

Recombinant human interleukin 6 in metastatic renal cell cancer: a phase II trial.
por: Stouthard, J. M., et al.
Publicado: (1996)

A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma
por: Kessler, Elizabeth R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qpaq2iv39l19hc492lg5rbnfpb